title: Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
authors.affiliation: Haemostasis Research Unit, Department of Haematology, University College London, London, UK. d.arachchillage@ucl.ac.uk.
authors.forename: D R J
authors.initials: DR
authors.lastname: Arachchillage
authors.affiliation: Haemostasis Research Unit, Department of Haematology, University College London, London, UK.
authors.forename: S J
authors.initials: SJ
authors.lastname: Machin
authors.affiliation: Haemostasis Research Unit, Department of Haematology, University College London, London, UK.|Departments of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: H
authors.initials: H
authors.lastname: Cohen
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000473:pathology / Q000628:therapy; D009471:Neuromyelitis Optica / Q000097:blood / Q000473:pathology / Q000628:therapy; D010951:Plasma Exchange; D011134:Polysaccharides / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux